Mark W. Ruddock

576 total citations
41 papers, 410 citations indexed

About

Mark W. Ruddock is a scholar working on Surgery, Molecular Biology and Nephrology. According to data from OpenAlex, Mark W. Ruddock has authored 41 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Molecular Biology and 8 papers in Nephrology. Recurrent topics in Mark W. Ruddock's work include Bladder and Urothelial Cancer Treatments (7 papers), Chronic Kidney Disease and Diabetes (4 papers) and Acute Kidney Injury Research (4 papers). Mark W. Ruddock is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Chronic Kidney Disease and Diabetes (4 papers) and Acute Kidney Injury Research (4 papers). Mark W. Ruddock collaborates with scholars based in United Kingdom, Ireland and United States. Mark W. Ruddock's co-authors include Tara Moore, John Lamont, David G. Hirst, Christopher J. McNally, Declan J. McKenna, Edwin J. Landaker, Mary Jo Kurth, Robert C. Cooksey, Mary‐Elizabeth Patti and Joseph Park and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Mark W. Ruddock

37 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Ruddock United Kingdom 12 150 81 51 47 46 41 410
Yijun Song China 14 154 1.0× 45 0.6× 33 0.6× 30 0.6× 30 0.7× 50 752
Patrick Pattee United States 11 208 1.4× 36 0.4× 23 0.5× 47 1.0× 67 1.5× 13 590
Aroa S. Maroto Spain 16 258 1.7× 67 0.8× 51 1.0× 30 0.6× 82 1.8× 29 609
Xiaofang Shen China 12 124 0.8× 32 0.4× 63 1.2× 19 0.4× 72 1.6× 25 413
Mindi Zhao China 9 211 1.4× 34 0.4× 22 0.4× 36 0.8× 45 1.0× 21 390
Jennifer E. Huffman United States 18 318 2.1× 59 0.7× 60 1.2× 34 0.7× 11 0.2× 37 757
Wenqing Yin United States 13 200 1.3× 38 0.5× 39 0.8× 41 0.9× 116 2.5× 25 564
Natascha Schweighofer Austria 14 225 1.5× 53 0.7× 70 1.4× 16 0.3× 18 0.4× 35 803
Thorsten Schmidt Germany 11 145 1.0× 44 0.5× 16 0.3× 38 0.8× 20 0.4× 21 549
Gourav Bhardwaj United States 15 311 2.1× 43 0.5× 66 1.3× 17 0.4× 32 0.7× 24 537

Countries citing papers authored by Mark W. Ruddock

Since Specialization
Citations

This map shows the geographic impact of Mark W. Ruddock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Ruddock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Ruddock more than expected).

Fields of papers citing papers by Mark W. Ruddock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Ruddock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Ruddock. The network helps show where Mark W. Ruddock may publish in the future.

Co-authorship network of co-authors of Mark W. Ruddock

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Ruddock. A scholar is included among the top collaborators of Mark W. Ruddock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Ruddock. Mark W. Ruddock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irvine, Allister, et al.. (2024). The Importance of Diagnostics in the Treatment of Urinary Tract Infections in the United Kingdom. Research and Reports in Urology. Volume 16. 327–335.
2.
Watson, Christopher J.E., Mark W. Ruddock, Mary Jo Kurth, et al.. (2024). Feto‐maternal indicators of cardiac dysfunction as a justification for the cardiac origins for pre‐eclampsia. International Journal of Gynecology & Obstetrics. 167(3). 941–948.
3.
Nesbit, M. Andrew, Mark W. Ruddock, Paul Brennan, et al.. (2022). A novel algorithm for cardiovascular screening using conjunctival microcirculatory parameters and blood biomarkers. Scientific Reports. 12(1). 6545–6545. 8 indexed citations
4.
Duggan, Brian, Declan O’Rourke, Neil Anderson, et al.. (2022). Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific. Frontiers in Oncology. 12. 1009014–1009014. 4 indexed citations
5.
6.
McBride, William T., et al.. (2021). Blood and urinary cytokine balance and renal outcomes at cardiac surgery. BMC Nephrology. 22(1). 406–406. 4 indexed citations
7.
Lamont, John, et al.. (2020). <p>Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival</p>. Research and Reports in Urology. Volume 12. 157–165. 5 indexed citations
8.
McNally, Christopher J., Mark W. Ruddock, Tara Moore, & Declan J. McKenna. (2020). <p>Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review</p>. Cancer Management and Research. Volume 12. 5225–5241. 46 indexed citations
9.
Kurth, Mary Jo, et al.. (2020). Acute kidney injury risk in orthopaedic trauma patients pre and post surgery using a biomarker algorithm and clinical risk score. Scientific Reports. 10(1). 20005–20005. 13 indexed citations
10.
McBride, William T., Mary Jo Kurth, John Lamont, et al.. (2019). Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score. Scientific Reports. 9(1). 16963–16963. 22 indexed citations
11.
Kurth, Mary Jo, et al.. (2019). An Algorithm Based on Combining hs-cTnT and H-FABP for Ruling Out Acute Myocardial Infarction. Computing in Cardiology Conference. 1–4. 1 indexed citations
12.
13.
Wilson, Mark W. B., Dawn E. Balmer, Mark W. Ruddock, et al.. (2018). The breeding population of Peregrine FalconFalco peregrinusin the United Kingdom, Isle of Man and Channel Islands in 2014. Bird Study. 65(1). 1–19. 18 indexed citations
14.
Emmert‐Streib, Frank, Ricardo De Matos Simoes, Brian Duggan, et al.. (2013). Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data. BMC Medicine. 11(1). 12–12. 11 indexed citations
15.
Anderson, Elizabeth, Margaret A. Smith, Mark W. Ruddock, et al.. (2013). A novel bioluminescent bacterial biosensor for measurement of Ara-CTP and cytarabine potentiation by fludarabine in seven leukaemic cell lines. Leukemia Research. 37(6). 690–696. 6 indexed citations
16.
Stevenson, Michael, et al.. (2012). Standardization of Diagnostic Biomarker Concentrations in Urine: The Hematuria Caveat. PLoS ONE. 7(12). e53354–e53354. 24 indexed citations
17.
Ruddock, Mark W., Michael Stevenson, Joe M. O’Sullivan, et al.. (2011). The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria. Cancer. 118(10). 2641–2650. 35 indexed citations
18.
Ruddock, Mark W., et al.. (2000). The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle. Radiotherapy and Oncology. 56(2). 253–257. 9 indexed citations
19.
Ruddock, Mark W., Stephanie McKeown, Lynn Murphy, et al.. (2000). Contractile properties of human renal cell carcinoma recruited arteries and their response to nicotinamide. Radiotherapy and Oncology. 54(2). 179–184. 8 indexed citations
20.
Ruddock, Mark W., et al.. (1999). Nicotinamide-inhibited vasoconstriction: lack of dependence on agonist signalling pathways. European Journal of Pharmacology. 374(2). 213–220. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yijun Song Breakdown of academic impact, for papers by Patrick Pattee Breakdown of academic impact, for papers by Aroa S. Maroto Breakdown of academic impact, for papers by Xiaofang Shen Breakdown of academic impact, for papers by Mindi Zhao Breakdown of academic impact, for papers by Jennifer E. Huffman Breakdown of academic impact, for papers by Wenqing Yin Breakdown of academic impact, for papers by Natascha Schweighofer Breakdown of academic impact, for papers by Thorsten Schmidt Breakdown of academic impact, for papers by Gourav Bhardwaj
Rankless by CCL
2026